Literature DB >> 9073146

Significance of intestinal metaplasia in different areas of esophagus including esophagogastric junction.

N Chalasani1, J M Wo, J G Hunter, J P Waring.   

Abstract

Over the past two decades, the incidence of adenocarcinoma of the esophagus and gastric cardia has increased at a rate exceeding that of any other cancer. Barrett's esophagus is the only known risk factor for these malignancies. Recently, emphasis has been placed on the significance of specialized intestinal metaplasia (SIM) on esophageal biopsies. Our aim was to compare the prevalence of SIM at different esophageal locations in patients who are at higher risk of developing esophageal adenocarcinoma (Caucasians) and patients with lower risk of developing esophageal adenocarcinoma (African-Americans). Eighty-seven unselected patients (42 Caucasians and 45 African-Americans) underwent routine upper endoscopy with biopsies from the proximal margin of columnar mucosa. We classified patients into those with a columnar-lined esophagus with SIM (CLE with SIM); CLE without SIM; or SIM with a normal-appearing gastroesophageal junction (SIM-GEJ). The prevalence of CLE with SIM, CLE without SIM, and SIM-GEJ was 28%, 10%, and 10% in Caucasians compared to 0%, 18% and 11% in African-Americans (P = 0.0001, 0.26, and 0.81, respectively). We found CLE with SIM only in patients with reflux symptoms at least twice a week. It is concluded that CLE with SIM is seen most commonly in patients thought to be at risk for esophageal adenocarcinoma (Caucasians with reflux symptoms). It is rarely seen in other groups with lower risk for this malignancy (African-Americans, nonrefluxers). Conversely, SIM-GEJ and CLE without SIM are common in all groups and are of questionable significance.

Entities:  

Mesh:

Year:  1997        PMID: 9073146     DOI: 10.1023/a:1018863529777

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  27 in total

1.  Barrett's esophagus and adenocarcinoma of the esophagus and gastroesophageal junction.

Authors:  F G Duhaylongsod; W G Wolfe
Journal:  J Thorac Cardiovasc Surg       Date:  1991-07       Impact factor: 5.209

2.  Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings.

Authors:  A J Cameron; A R Zinsmeister; D J Ballard; J A Carney
Journal:  Gastroenterology       Date:  1990-10       Impact factor: 22.682

Review 3.  Barrett's esophagus.

Authors:  S J Spechler; R K Goyal
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

4.  Diagnostic inconsistencies in Barrett's esophagus. Department of Veterans Affairs Gastroesophageal Reflux Study Group.

Authors:  S L Kim; J P Waring; S J Spechler; R E Sampliner; W G Doos; W F Krol; W O Williford
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

5.  The columnar-lined esophagus (Barrett syndrome)--an acquired condition?

Authors:  S M Mossberg
Journal:  Gastroenterology       Date:  1966-05       Impact factor: 22.682

6.  Barrett's esophagus: development of dysplasia and adenocarcinoma.

Authors:  W Hameeteman; G N Tytgat; H J Houthoff; J G van den Tweel
Journal:  Gastroenterology       Date:  1989-05       Impact factor: 22.682

7.  Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease.

Authors:  C Winters; T J Spurling; S J Chobanian; D J Curtis; R L Esposito; J F Hacker; D A Johnson; D F Cruess; J D Cotelingam; M S Gurney
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

8.  Is Barrett's metaplasia the source of adenocarcinomas of the cardia?

Authors:  G W Clark; T C Smyrk; P Burdiles; S F Hoeft; J H Peters; M Kiyabu; R A Hinder; C G Bremner; T R DeMeester
Journal:  Arch Surg       Date:  1994-06

9.  Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus.

Authors:  R C Haggitt; J Tryzelaar; F H Ellis; H Colcher
Journal:  Am J Clin Pathol       Date:  1978-07       Impact factor: 2.493

10.  Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux.

Authors:  M G Sarr; S R Hamilton; G C Marrone; J L Cameron
Journal:  Am J Surg       Date:  1985-01       Impact factor: 2.565

View more
  16 in total

Review 1.  Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.

Authors:  J A Jankowski; N A Wright; S J Meltzer; G Triadafilopoulos; K Geboes; A G Casson; D Kerr; L S Young
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

Review 2.  The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.

Authors:  P Malfertheiner; U Peitz
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

3.  Comparison of reflux esophagitis and its complications between African Americans and non-Hispanic whites.

Authors:  Kenneth J Vega; Sian Chisholm; M Mazen Jamal
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

4.  African Americans with Barrett's esophagus are less likely to have dysplasia at biopsy.

Authors:  Joe E Khoury; Sian Chisholm; M Mazen Jamal; Carlos Palacio; Sunitha Pudhota; Kenneth J Vega
Journal:  Dig Dis Sci       Date:  2011-09-11       Impact factor: 3.199

Review 5.  Meta-analyses of the effect of symptoms of gastroesophageal reflux on the risk of Barrett's esophagus.

Authors:  Justin B Taylor; Joel H Rubenstein
Journal:  Am J Gastroenterol       Date:  2010-05-18       Impact factor: 10.864

6.  IMportance of an Irregular Z Line: Is Barrett's in the Eye of the Beholder?

Authors:  Swathi Eluri; Nicholas J Shaheen
Journal:  Dig Dis Sci       Date:  2018-06       Impact factor: 3.199

Review 7.  Surgical management of esophagogastric junction tumors.

Authors:  Burkhard H A von Rahden; Hubert J Stein; J Rüdiger Siewert
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

Review 8.  Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction.

Authors:  Manuel Pera
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

Review 9.  Role of surveillance in intestinal metaplasia of the esophagus and gastroesophageal junction.

Authors:  Guido N J Tytgat; Johanna W Van Sandick; J Jan B van Lanschot; Huug Obertop
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

Review 10.  Effect of Helicobacter pylori infection in Barrett's esophagus and the genesis of esophageal adenocarcinoma.

Authors:  Geoffrey W B Clark
Journal:  World J Surg       Date:  2003-07-24       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.